SCHEMBL4877091

SCHEMBL4877091

Cc1ncccc1OCCN1CCN(C2=COC(C3=CC=CCC3)=CO2)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 5/20 0.35
HTR1D P28221 3/20 0.35
HTR1B P28222 3/20 0.35
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
ABCB1 P08183 2/20 0.34
DRD2 P14416 2/20 0.34
DRD3 P35462 2/20 0.34
ADRB2 P07550 1/20 0.34
HTR2C P28335 1/20 0.34
HTR1F P30939 1/20 0.34
HTR7 P34969 1/20 0.34
ADRA1B P35368 1/20 0.34
HTR2B P41595 1/20 0.34
HTR5A P47898 1/20 0.34
CHRNB1 P11230 1/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4871961 0.89 SLC6A2 (0.34) HTR1ASLC6A2SLC6A4SLC6A3ABCB1
SCHEMBL4877185 0.89 SLC6A2 (0.34) HTR1AHTR1DHTR1BSLC6A2SLC6A4
SCHEMBL7130709 0.85 L3MBTL1 (0.41) HTR1AABCB1DRD2DRD3DRD1
SCHEMBL7128136 0.83 ALDH1A1 (0.42) HTR1ADRD2HTR7TDP1HTR2A
SCHEMBL7127097 0.82 DRD2 (0.43) HTR1AHTR1DHTR1BDRD2DRD3
SCHEMBL7125207 0.80 KDM4E (0.47) HTR1ADRD2DRD3HRH3DRD1
SCHEMBL7128466 0.80 L3MBTL1 (0.47) HTR1ADRD2DRD3HRH3HTR2A
SCHEMBL7124339 0.79 HTR1A (0.40) HTR1ASLC6A4DRD2DRD3HTR7
SCHEMBL7127138 0.78 HTR1A (0.44) HTR1ADRD2DRD3HTR7HRH3
SCHEMBL7118625 0.77 ALDH1A1 (0.53) ABCB1DRD2DRD3ADRB2DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7393845-B2 Heteroaryl derivates, their preparation and use H. LUNDBECK A/S (DK) 2008-07-01 US claimed
US-20080027071-A1 Novel heteroaryl derivatives, their preparation and use H. LUNDBECK A/S (DK) 2008-01-31 US claimed
EP-1399438-B1 NOVEL HETEROARYL DERIVATIVES, THEIR PREPARATION AND USE LUNDBECK & CO AS H (DK) 2005-12-07 EP claimed
US-20040248883-A1 Novel heteroaryl derivatives, their preparation and use H. LUNDBECK A/S (DK) 2004-12-09 US claimed
US-7393845-B2 Heteroaryl derivates, their preparation and use H. LUNDBECK A/S (DK) 2008-07-01 US disclosed
US-20080027071-A1 Novel heteroaryl derivatives, their preparation and use H. LUNDBECK A/S (DK) 2008-01-31 US disclosed
US-20040248883-A1 Novel heteroaryl derivatives, their preparation and use H. LUNDBECK A/S (DK) 2004-12-09 US disclosed
EP-1399438-A1 NOVEL HETEROARYL DERIVATIVES, THEIR PREPARATION AND USE H. Lundbeck A/S (DK) 2004-03-24 EP disclosed
WO-2003002556-A1 NOVEL HETEROARYL DERIVATIVES, THEIR PREPARATION AND USE H. LUNDBECK A/S (DK) 2003-01-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248883-A1 Novel heteroaryl derivatives, their preparation and use GRIN2C, GRIN2B, HTR1A HTR1A 3/4885HTR1D 13/4885HTR1B 6/4885
US-20080027071-A1 Novel heteroaryl derivatives, their preparation and use GRIN2C, GRIN2B, HTR2C HTR1A 28/4885HTR1D 56/4885HTR1B 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.